文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

中国武汉2019新型冠状病毒感染患者的临床特征

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
PubMed 文献 · Lancet · 2020-01-24
一句话结论武汉41例实验室确诊2019-nCoV感染患者中,66%有华南海鲜市场暴露,常见起病症状为发热、咳嗽、肌痛或乏力,32%入住ICU,15%死亡。

该研究前瞻性收集并分析了2020年1月2日前武汉某定点医院41例经实时RT-PCR和二代测序实验室确诊的2019-nCoV感染住院患者的流行病学、临床、实验室和影像学特征及治疗与临床结局。患者以男性为主(30/41,73%),中位年龄49.0岁(IQR 41.0-58.0),27例(66%)有华南海鲜市场暴露,发现一个家庭聚集性。起病常见症状为发热(40/41,98%)、咳嗽(31/41,76%)和肌痛或乏力(18/41,44%);全部41例胸部CT均有肺炎异常表现。并发症包括急性呼吸窘迫综合征(12例,29%)、RNAaemia(6例,15%)、急性心脏损伤(5例,12%)和继发感染(4例,10%)。13例(32%)入住ICU,6例(15%)死亡;与未入住ICU患者相比,ICU患者血浆IL2、IL7、IL10、GSCF、IP10、MCP1、MIP1A和TNFα水平更高。

要点

  • 41例实验室确诊2019-nCoV感染住院患者中,13例(32%)入住ICU,6例(15%)死亡。
  • 与未入住ICU患者相比,ICU患者血浆IL2、IL7、IL10、GSCF、IP10、MCP1、MIP1A和TNFα水平更高。
  • 全部41例患者胸部CT均有肺炎异常表现;并发症包括急性呼吸窘迫综合征12例(29%)、RNAaemia 6例(15%)、急性心脏损伤5例(12%)、继发感染4例(10%)。
  • 起病常见症状为发热(40/41,98%)、咳嗽(31/41,76%)、肌痛或乏力(18/41,44%);呼吸困难出现在22/40例(55%),从起病到呼吸困难的中位时间为8.0天(IQR 5.0-13.0)。
  • 26/41例(63%)有淋巴细胞减少;27/41例(66%)有华南海鲜市场暴露,发现一个家庭聚集性。

适用人群与场景

  • 2020年1月2日前入住武汉某定点医院的疑似2019-nCoV感染患者,经实时RT-PCR和二代测序实验室确诊2019-nCoV感染。
  • 研究纳入41例住院患者,其中13例入住ICU、28例未入住ICU。

红旗征与不能漏的情况

  • 呼吸困难出现在22/40例(55%),从起病到呼吸困难的中位时间为8.0天(IQR 5.0-13.0)。
  • 并发症包括急性呼吸窘迫综合征12例(29%)、RNAaemia 6例(15%)、急性心脏损伤5例(12%)和继发感染4例(10%)。

研究设计与关键结果

  • 研究类型为前瞻性病例系列,纳入2020年1月2日前武汉某定点医院41例实验室确诊2019-nCoV感染住院患者。
  • 患者中男性30例(73%),有基础疾病13例(32%),包括糖尿病8例(20%)、高血压6例(15%)、心血管疾病6例(15%);中位年龄49.0岁(IQR 41.0-58.0)。
  • 27例(66%)有华南海鲜市场暴露,发现一个家庭聚集性。
  • 起病常见症状为发热40/41例(98%)、咳嗽31/41例(76%)、肌痛或乏力18/41例(44%);较不常见症状为咳痰11/39例(28%)、头痛3/38例(8%)、咯血2/39例(5%)、腹泻1/38例(3%)。
  • 26/41例(63%)有淋巴细胞减少;全部41例胸部CT均有肺炎异常表现。
  • 13例(32%)入住ICU,6例(15%)死亡;与未入住ICU患者相比,ICU患者血浆IL2、IL7、IL10、GSCF、IP10、MCP1、MIP1A和TNFα水平更高。

证据类型、等级与局限

  • 证据类型为前瞻性病例系列,单中心,样本量41例。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,2019-nCoV感染引起类似严重急性呼吸综合征冠状病毒的严重呼吸道疾病聚集性疫情,与入住ICU和高死亡率相关。
  • 作者认为,对2019-nCoV起源、流行病学、人际传播持续时间和疾病临床谱的主要知识空白需未来研究填补。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients.

METHODS: All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. Data were obtained with standardised data collection forms shared by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. Researchers also directly communicated with patients or their families to ascertain epidemiological and symptom data. Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not.

FINDINGS: By Jan 2, 2020, 41 admitted hospital patients had been identified as having laboratory-confirmed 2019-nCoV infection. Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]). Median age was 49·0 years (IQR 41·0-58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market. One family cluster was found. Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum production (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38). Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0-13·0]). 26 (63%) of 41 patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included acute respiratory distress syndrome (12 [29%]), RNAaemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died. Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα.

INTERPRETATION: The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies.

FUNDING: Ministry of Science and Technology, Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technology Commission.

来源:Lancet,查看原文。版权归原作者所有。

参考来源

  1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. PMID: 31986264. doi:10.1016/S0140-6736(20)30183-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。